BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29165785)

  • 1. Genomic profiles of nasopharyngeal carcinoma: The importance of histological subtyping and Epstein-Barr virus in situ assays.
    Lui VWY; To KF; Lo KW
    Cancer; 2018 Jan; 124(2):434-435. PubMed ID: 29165785
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Genomic profiles of nasopharyngeal carcinoma: The importance of histological subtyping and Epstein-Barr virus in situ assays.
    Ali SM; Ross JS; Wang K
    Cancer; 2018 Jan; 124(2):435-436. PubMed ID: 29165787
    [No Abstract]   [Full Text] [Related]  

  • 3. A novel Epstein-Barr virus subtype associated with nasopharyngeal carcinoma found in South China.
    Young LS
    Cancer Commun (Lond); 2020 Jan; 40(1):60-62. PubMed ID: 32077639
    [No Abstract]   [Full Text] [Related]  

  • 4. Ubiquitous Distribution of Epstein-Barr Virus and the Highly Uneven Distribution of Nasopharyngeal Carcinoma.
    Wang CQ; He J
    Chin Med J (Engl); 2016 Oct; 129(20):2506-2507. PubMed ID: 27748347
    [No Abstract]   [Full Text] [Related]  

  • 5. Frequency of Epstein-Barr virus and human papilloma virus in patients with nasopharyngeal carcinoma.
    Altekin I; Taş A; Yalcin O; Guven SG; Aslan Z; Adali MK; Karasalihoğlu AR
    Eur Arch Otorhinolaryngol; 2020 Jul; 277(7):2041-2047. PubMed ID: 32170419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus infection and nasopharyngeal carcinoma.
    Tsao SW; Tsang CM; Lo KW
    Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cancer-associated Epstein-Barr virus variant with epithelial tropism.
    Frappier L
    Trends Microbiol; 2013 Dec; 21(12):616-7. PubMed ID: 24183509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronous occurrence of nasopharyngeal carcinoma and Hodgkin lymphoma.
    Stokken J; Manz RM; Flagg A; Kate Gowans L; Anne S
    Int J Pediatr Otorhinolaryngol; 2014 Jan; 78(1):154-6. PubMed ID: 24290306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasopharyngeal carcinoma.
    Kamran SC; Riaz N; Lee N
    Surg Oncol Clin N Am; 2015 Jul; 24(3):547-61. PubMed ID: 25979399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metachronous occurrence of Epstein-Barr virus-associated primary ovarian Burkitt lymphoma and second primary nasopharyngeal carcinoma.
    Chou CT; Chang KC; Hsiao JR; Su YC; Ou CY
    Pathol Int; 2022 Apr; 72(4):261-263. PubMed ID: 35128744
    [No Abstract]   [Full Text] [Related]  

  • 11. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
    Ramayanti O; Juwana H; Verkuijlen SA; Adham M; Pegtel MD; Greijer AE; Middeldorp JM
    Int J Cancer; 2017 Jan; 140(1):149-162. PubMed ID: 27600027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma.
    Chan KC
    Chin J Cancer; 2014 Dec; 33(12):598-603. PubMed ID: 25418194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr Virus in Nasopharyngeal Carcinoma of Guatemalan and Brazilian Patients.
    Rumayor Piña A; Dos Santos HT; Carlos R; Altemani A; de Almeida OP
    Int J Surg Pathol; 2017 Jun; 25(4):304-309. PubMed ID: 27881609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Epstein-Barr virus DNA in formalin-fixed paraffin-embedded tissue of nasopharyngeal carcinoma using polymerase chain reaction and in situ hybridization.
    Akao I; Sato Y; Mukai K; Uhara H; Furuya S; Hoshikawa T; Shimosato Y; Takeyama I
    Laryngoscope; 1991 Mar; 101(3):279-83. PubMed ID: 1847985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China.
    Zheng XH; Lu LX; Li XZ; Jia WH
    Cancer Sci; 2015 Sep; 106(9):1196-201. PubMed ID: 26082292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of nasal and nasopharyngeal swab collection for the detection of Epstein-Barr virus in nasopharyngeal carcinoma.
    Coghill AE; Wang CP; Verkuijilen SAWM; Yu KJ; Hsu WL; Middeldorp JM; Hildesheim A
    J Med Virol; 2018 Jan; 90(1):191-195. PubMed ID: 28833336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma.
    Fung SY; Lam JW; Chan KC
    Chin Clin Oncol; 2016 Apr; 5(2):18. PubMed ID: 27121878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus at 50-future perspectives.
    Young LS
    Chin J Cancer; 2014 Nov; 33(11):527-8. PubMed ID: 25367333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma.
    Lung ML; Cheung AK; Ko JM; Lung HL; Cheng Y; Dai W
    Chin J Cancer; 2014 Nov; 33(11):556-68. PubMed ID: 25367335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M2-polarized tumour-associated macrophages in stroma correlate with poor prognosis and Epstein-Barr viral infection in nasopharyngeal carcinoma.
    Huang H; Liu X; Zhao F; Lu J; Zhang B; Peng X; Zhang M; Chen X; Li G; Li X
    Acta Otolaryngol; 2017 Aug; 137(8):888-894. PubMed ID: 28395580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.